DrBurns’ ReLeaf CBD Lozenge Review

DrBurns’ ReLeaf CBD Lozenge Review

DrBurns’ ReLeaf CBD Lozenge Review

In this review, we will be evaluating DrBurns’ ReLeaf™ CBD Soothing Lozenge (10 mg Honey-Lemon). This is the second product we are reviewing from this manufacturer; we previously raved about DrBurns’ ReLeaf™ CBD Pure PAIN Tincture, which became our top recommended CBD product after our testing and review. So naturally, we will be expecting the same high standards and results as we experienced before.

Table of Contents

DrBurns’ ReLeaf™

Our previous review introduced you to DrBurns’ ReLeaf™ and its founder and product formulator, Dr. Elaine Burns, an Arizona-licensed and board-certified Naturopathic Medical Doctor (NMD). Her past experience and involvement working with medical marijuana patients, with a particular focus on CBD, at Southwest Medical Marijuana Evaluation Centers, which she established and directed for its first six years, perfectly positioned her to pursue her passion of using natural medicines and plants to help people recover from illnesses, injuries, and other stress-related troubles.

During her tenure there, she saw consistent results with the many patients working with her for alleviation of a wide variety of ailments and conditions. Dr. Burns also noticed that higher concentrations of CBD, or pure CBD applications, were producing even more noticeable and significant results, causing her to shift her focus towards CBD-related formulations and treatments. By combining her knowledge and experience of formulating organic botanical compounds to treat specific needs or illnesses with the healing power of CBD, DrBurns’ ReLeaf™ now offers an impressive line of 21 products, targeting various ailments or conditions such as migraines, menopausal discomfort, opioid withdrawals, and gastrointestinal complications, to name just a few.

CBD Soothing Lozenge (10 mg Honey-Lemon)

For this review, we tested their CBD Soothing Lozenges, listed in their General Wellness category of their products. The package contains 60 lozenges, with 10 mg CBD per lozenge, for a total of 600 mg.

The product information sheet for their CBD Soothing Lozenges suggests usage in cases of seizures, anxiety, and/or insomnia. It also notes that higher dosages may be effective in treating seizure disorders.

The report continues by listing its five Mechanisms of Action:

  • Analgesic – works to reduce pain
  • Anticonvulsant – reduces seizure activity
  • Antispasmodic – treats muscle spasms
  • Anxiolytic – reduces anxiety levels
  • Nervine – a nerve-calming agent

The ingredients used in formulating the CBD Soothing Lozenge are straightforward and kept to the minimum:

  • Cannabidiol Concentrate – the essence of the lozenge, this is the medication you are seeking
  • Sugar – the common natural sweetener, intended to counteract any possible bitter taste
  • Water – nothing can be purer than water, so it isn’t even an additive per se
  • Corn Syrup – commonly used to prevent sugar crystallization, enhance flavor, and soften the texture
  • Food Grade Flavoring – a concentrated flavoring meeting the “generally recognized as safe” standard
  • Gel Coloring – flavor-free, this ingredient creates a consistent honey-yellow coloring to the lozenge

As with their tinctures, they only use ingredients crucial to the formulation and delivery of the product. Once again, we remain impressed by their transparency in sharing the ingredients used in their lozenges. Now on to the next stage, which we look forward to with great anticipation and excitement: the testing of the product and subsequent reporting to you!


The CBD Informative Testing and Rating

Admittedly, after the incredibly accurate results of our third-party report on DrBurns’ ReLeaf™ CBD Pure PAIN Tincture, where the CBD analysis showed an astonishing 0.315 deviancy from the company claim of CBD content (13.15 mg as compared to the 1200 mg label), we were hoping for another amazingly narrow deviance for their CBD Soothing Lozenges. In the spirit of continuity (and because they are just so darn good!), we once again relied on our favorite and accurate third-party testing facility, Level One Labs in Arizona, to perform their magic and deliver us their expert, unbiased analysis.


Third Party Test Results

What the label says and what our third party lab found:

  • 10

    mg – Company’s Claim

  • 13.15

    mg – Our Test

  • 31.5%

    – Variance

We have established a deviation standard when comparing content, looking for third-party test results to end within a range of 10% of the content as printed on the label.

Just as we were shocked by the 99.5% accuracy rating on the last report, we were rather stunned to find our first product where the deviation exceeded 10% of the label claim! While they erred on the positive side, the Level One Certificate of Analysis indicated the 10 mg lozenge showed a CBD content level of mg, which is way over a 10% deviance (a whopping 0.315 deviance, to be precise!). While some may wish to argue that the consumer is not being shortchanged, since the deviance leaned towards their favor, accurate dosing is important and too much deviance in either direction makes it more difficult to determine which dosages work best for the patient.

We also want to note that this product contains isolate CBD, the only cannabinoid known to see its potency increase the longer it stays on a shelf. If the product we sent to Level One for testing happened to be in inventory longer than normal, this could definitely impact the deviancy factor. Also, as percentage is factored by weight, we need to account for a deviancy for this, which may have tilted the number beyond our standard 10% factor.

Based upon the reported deviancy, countered with the fact that aging and weight may have contributed to the final result, we gave a 7.85 out of 10 quality rating for independent lab testing.


CBD Informative Assessment

Even after reading this report, our testers were curious to experience the lozenges in action. Recognizing that our testing team are capable CBD consumers, they were not daunted or unnecessarily concerned about overdosing. So our intrepid testers forged ahead, unconcerned for their own safety, all in the name of an improved and happier CBD world!


The Manufacturer – DrBurns’ ReLeaf™

For the second time, we are pretty impressed by the packaging that DrBurns’ ReLeaf™ puts together for their products. Again we are fans of their designs and packaging, appreciating the care and attention to detail. However, we have one modest gripe, which is they do not capture the natural gleam of the lozenges, which are stunningly eye-catching when you bring a lozenge into the natural daylight. Considering this a minor infraction in the packaging, we gave an overall rating of 9.5 out of 10.

The Product – CBD Soothing Lozenge

Our testers appreciate honey and lemon flavoring, as they are both subtle tastes without a tendency to leave any aftertaste. They did notice some other taste underneath the honey-lemon but could not readily pinpoint it. It almost had hints of bitterness, but it was not a lasting sensation or too strongly noticeable. However, due to the fact that we all did a kind of double-take (or double-taste?) on that mystery under-flavor, we agreed upon an 8 out of 10 rating for taste.

Maybe it’s because the CBD Soothing Lozenge came on the heels of their CBD Pure PAIN Tincture, which knocked it out of the park with a 10 out of 10 rating on effects, but we felt it did not earn an equal rating for effects. On the other hand, compared to many CBD products we have tested, this product stands up well in the effects department, earning it a 8 out of 10 rating.

The CBD Informative Overall Rating for DrBurns’ ReLeaf™ CBD Soothing Lozenge – 8.09

Even though it stands a bit in the shadow of its partner product, DrBurns’ ReLeaf™ CBD Soothing Lozenge still has lots going for it and deserves a good endorsement. While not our very top CDB product pick, we can say with certainty that this is product worthy of purchase and consumption and to this end it has earned an overall 8.09 rating.

This Arizona business wants to bring credibility to the medical cannabis industry

This Arizona business wants to bring credibility to the medical cannabis industry

This Arizona business wants to bring credibility to the medical cannabis industry

Arizona business is ready to sell marijuana as the alternative to traditional medicine.
This Ariz. doctor was hoping to change the way we see medical marijuana when she opened Southwest Medical Marijuana Evaluation Center in 2011.

After medical marijuana was legalized in Arizona in 2011, dispensaries popped up all over the Valley ready to sell the alternative to traditional medicine to those deemed qualified.

For Elaine Burns, an Arizona-licensed and board-certified naturopathic medical doctor and strong supporter of medical cannabis, the question wasn’t whether patients had legitimate health concerns that warranted the treatment. It was whether those issuing medical marijuana cards and offering advice were capable and suited to do so.

If the medical cannabis industry were to grow and gain credibility, she knew there needed to be a better method. Burns provided that when she opened the Southwest Medical Marijuana Evaluation Center in 2011.

“(For) most patients, it’s not the card. It’s the medicine behind the card to help them get better. How can they get better if there’s no physician to give them input?” Burns said. “Often, it’s a young person at the dispensary who has no clue about medical conditions.”

Dr. Burns will see you now

Burns was the first Arizona physician to pass the American Academy of Cannabinoid Medicine’s physician certification test, making her the state’s first certified expert in the field. In 2012, she opened her second office in Phoenix and a third in Avondale in 2016. She helms one of the few female-owned and physician-run medical marijuana evaluation centers in Arizona, one of 33 states where the treatment is legal.

Her specialization in naturopathic medicine, she explained, puts her in a better position to evaluate and diagnose those who haven’t found relief in traditional medication. Burns’ reputation has made her a go-to for neurologists, orthopedic surgeons, Alzheimer’s doctors and hospitals like the Barrow Neurological Institute, who refer their patients to Burns, she said.

At least 30 percent of Burns’ patients are physician referrals, she said. Many are elderly and live in Sun City. When Burns opened her first center, she saw 50 patients a week. Today, 200 are treated at the center’s three offices. She has a small team of rotating independently contracted physicians to assist her with patients.

Chronic back pain sufferers are Burns’ largest patient group. Some have epilepsy and Multiple Sclerosis. Her youngest patient was a 5-year-old with a severe neurologic condition.

“Physicians are the gatekeepers for patients getting into the medical marijuana program. I knew that mainstream physicians don’t have the medical training and knowledge of plant-based medicines like a naturopathic medical doctor does,” Burns said. “We were able to forge a path where we are a trusted source for the medical community.”

The treatment

Many patients come to the center because their conditions have stumped a bevy of traditional medical professionals.

For 16 years, Theresa Morris suffered from chronic diarrhea, which emerged in 2003, two years after Morris underwent surgery and completed chemotherapy for colon cancer. Physicians and specialists prescribed her a laundry list of medications that only exacerbated the situation with a variety of painful side effects and no relief for her original issue, which was starting to get worse.

Morris lives in Claymont, Del., and is a friend of Burns. In April, Morris came to Arizona on vacation with her granddaughter. She had been telling Burns about her health problems and for the first time, Morris said she felt that someone was actually getting it.

“She really listens, and that was a big part of it,” Morris said.

Burns prescribed one of her physician-formulated cannabis oils, which is part of a line of oils and ointments she recently launched, that does not have THC, the compound in marijuana responsible for the “high.”

Morris put the oil under her tongue. Within a half-hour after her first dose in May, Morris experienced positive signs of recovery that she hadn’t felt in years. She has since weaned herself completely off of it and has not had any negative symptoms since her last dose four weeks ago.


“It’s a miracle. A thousand thank-yous isn’t enough. This oil has changed my life. It’s the real McCoy,” said Morris, who also uses a Burns-prescribed arthritis cream. “She’s not just selling these products. She knows the history (of medical cannabis), she knows the doses and she takes the time to know your (medical) history.”

Gaining credibility

A firm believer in cannabis’ abilities to effectively treat and relieve symptoms stemming from a variety of medical conditions from chronic pain to tumors, Burns also addresses patients’ wanting to reduce their intake of opioids and other addictive treatments.

She’s not alone. Overall, 71 percent of medical cannabis consumers reduced or stopped their over-the-counter pain treatment and 60 percent have reduced or stopped their alcohol consumption, according to a survey by Eaze, an online cannabis marketplace and delivery platform. Additionally, CBD consumers doubled in 2018, with Baby Boomers being the most common among the age groups and one of the fastest-growing.

Over the years, medical marijuana has slowly gained credibility as a viable treatment option. Education has helped. But when Burns first opened her practice, times were different and she paid the price.

She talked about a credit card company that pulled its services for her business after finding out what industry she was in. Burns has had her share of red tape with insurance companies and financial institutions. She’s had undercover DEA agents walk in, posing as patients. Burns was called a “pot doctor” in the media and by healthcare and medical professionals, some who are part of the organizations and fields that send patients to her today.

It’s better now, but still a challenge. Making sure every aspect of her business runs above board is key to survival.

“It’s not a walk in the park from a business owner’s standpoint. It’s difficult to run as a business. It was absolutely a 100-percent risk for me to do this,” she said.

‘It’s not about just stamping a document’

Burns is in the process of rebranding her company to Southwest Medical Marijuana Physicians Group, which she said better represents what it does by providing a collaborative and dignified medical experience for patients rather than a business model fueled by what she called a “mill mentality.”

“We provide education and a treatment plan. It’s not about just stamping a document,” Burns said.

Shortly after Burns opened her Scottsdale office, a newspaper advertising representative stopped by. She had been making the rounds to various medical marijuana businesses that had opened upon legalization.

“I remember the look on her face. She said, ‘Oh my gosh, this looks like a doctor’s office.’ And I’m like, ‘Yes, because this is a doctor’s office.’ She told me that the others didn’t look like ours,” Burns recalled. “You have to provide a professional medical environment and from day one, that’s what we’ve done.”

Southwest Medical Marijuana Evaluation Center

Where: Scottsdale, Phoenix, Avondale
Employees: Five
Interesting stat: The global medical cannabis market is projected to reach $37 billion by 2023, according to market research firm Research and Markets.
Details: 480-656-2119, evaluationtoday.com